Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP419029.RAgBdoK0XHAhLYwOoX_f7vvFDctFIjN-yavfZsyrWxJlg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP419029.RAgBdoK0XHAhLYwOoX_f7vvFDctFIjN-yavfZsyrWxJlg130_assertion type Assertion NP419029.RAgBdoK0XHAhLYwOoX_f7vvFDctFIjN-yavfZsyrWxJlg130_head.
- NP419029.RAgBdoK0XHAhLYwOoX_f7vvFDctFIjN-yavfZsyrWxJlg130_assertion description "[Patients with renal involvement had increased surface expression of CXCR3 and CCR3 (P = 0.04 in both) and a lower level of soluble IP-10 compared with patients without renal disease (P = 0.025) and compared with controls (P = 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419029.RAgBdoK0XHAhLYwOoX_f7vvFDctFIjN-yavfZsyrWxJlg130_provenance.
- NP419029.RAgBdoK0XHAhLYwOoX_f7vvFDctFIjN-yavfZsyrWxJlg130_assertion evidence source_evidence_literature NP419029.RAgBdoK0XHAhLYwOoX_f7vvFDctFIjN-yavfZsyrWxJlg130_provenance.
- NP419029.RAgBdoK0XHAhLYwOoX_f7vvFDctFIjN-yavfZsyrWxJlg130_assertion SIO_000772 14596426 NP419029.RAgBdoK0XHAhLYwOoX_f7vvFDctFIjN-yavfZsyrWxJlg130_provenance.
- NP419029.RAgBdoK0XHAhLYwOoX_f7vvFDctFIjN-yavfZsyrWxJlg130_assertion wasDerivedFrom befree-2016 NP419029.RAgBdoK0XHAhLYwOoX_f7vvFDctFIjN-yavfZsyrWxJlg130_provenance.
- NP419029.RAgBdoK0XHAhLYwOoX_f7vvFDctFIjN-yavfZsyrWxJlg130_assertion wasGeneratedBy ECO_0000203 NP419029.RAgBdoK0XHAhLYwOoX_f7vvFDctFIjN-yavfZsyrWxJlg130_provenance.